Literature DB >> 5856336

Methylazo and methylazoxy compounds; new types of antitumour agents.

W Bollag, A Kaiser, A Langemann, P Zeller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1964        PMID： 5856336     DOI： 10.1007/bf02154074

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


× No keyword cloud information.
  4 in total

1.  THE TUMOR-INHIBITORY EFFECTS OF THE METHYLHYDRAZINE DERIVATIVE RO 4-6467/1 (NSC-77213).

Authors:  W BOLLAG
Journal:  Cancer Chemother Rep       Date:  1963-12

2.  Methylhydrazine derivatives, a new class of cytotoxic agents.

Authors:  P ZELLER; H GUTMANN; B HEGEDUS; A KAISER; A LANGEMANN; M MULLER
Journal:  Experientia       Date:  1963-03-15

3.  The degradation of deoxyribonucleic acid by new tumour inhibiting compounds: the intermediate formation of hydrogen peroxide.

Authors:  K BERNEIS; M KOFLER; W BOLLAG; A KAISER; A LANGEMANN
Journal:  Experientia       Date:  1963-03-15

4.  Tumour inhibitory effects of a new class of cytotoxic agents: methylhydrazine derivatives.

Authors:  W BOLLAG; E GRUNBERG
Journal:  Experientia       Date:  1963-03-15
  4 in total
  2 in total

Review 1.  N-methyl antitumour agents. A distinct class of anticancer drugs?

Authors:  D Newell; A Gescher; S Harland; D Ross; C Rutty
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  The in vivo cytotoxic activity of procarbazine and procarbazine metabolites against L1210 ascites leukemia cells in CDF1 mice and the effects of pretreatment with procarbazine, phenobarbital, diphenylhydantoin, and methylprednisolone upon in vivo procarbazine activity.

Authors:  D A Shiba; R J Weinkam
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.